New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
BACKGROUND: To better counsel vestibular schwannoma patients, it is necessary to understand the tumor control rates of stereotactic radiosurgery (SRS).OBJECTIVES: To determine tumor control rates, factors determining control and complication rates following SRS.METHODS: Tertiary hospital retrospective cohort.RESULTS: 579 tumors (576 patients) were treated with SRS. 477 tumors (474 patients, 82%) had =1?year follow up and 60% (344) =3?years follow up. 88% of tumors had primary SRS and 6.7% salvage SRS. Median follow up time was 4.6?years. At 3?years, the tumor control rate of primary SRS was 89% (258 of 290) in sporadic tumors compared to 43% in Neurofibromatosis type II (3 of 17) (p?
View details for DOI 10.1097/MAO.0000000000003285
View details for PubMedID 34353978